No reactivation of attenuated immunodeficiency viruses in rhesus macaques after vaccinia virus-induced immune activation.

References

1. Almond N., Kent K., Cranage M., Rud E., Clarke B., Stott E. J. 1995; Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345:1342–1344
   [Google Scholar]
2. Baba T. W., Jeong Y. S., Penninck D., Bronson R., Greene M. F., Ruprecht R. M. 1995; Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267:1820–1825
   [Google Scholar]
3. Corey L. 1995; Reducing T-cell activation as a therapy for human immunodeficiency virus infection. Journal of Infectious Diseases 171:521–522
   [Google Scholar]
4. Cranage M. P., Cook N., Johnstone P., Greenaway P., Kitchin P. A., Stott E. J., Almond N., Baskerville A. 1990; SIV infection of rhesus macaques: in vitro titration of infectivity and development of an experimental vaccine. In Animal Models in AIDS pp 103–114 Schnellkens H. Edited by Amsterdam: Elsevier;
   [Google Scholar]
5. Daniel M. D., Kirchhoff F., Czajak S. C., Sehgal P. K., Desrosiers R. C. 1992; Protective effect of a live-attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938–1941
   [Google Scholar]
6. Demkowicz W. E., Shin Maa J., Esteban M. 1992; Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans. Journal of Virology 66:386–398
   [Google Scholar]
7. Dittmer U., NiBlein T., Bodemer W., Petry H., Sauermann U., Stahl-Hennig C., Hunsmann G. 1995; Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus. Virology 212:392–397
   [Google Scholar]
8. Goletti D., Weissman D., Jackson R. W., Graham N. M. H., Vlahov D., Klein R. S., Munsiff S. S., Ortona L., Cauda R., Fauci A. S. 1996; Effect of Mycobacterium tuberculosis on HIV replication. Journal of Immunology 157:1271–1278
   [Google Scholar]
9. Igarashi R., Shibata R., Hasebe F., Ami Y., Shinohara K., Komatsu T., Stahl-Hennig C., Petry H., Hunsmann G., Kuwata T., Jin M., Adachi A., Kurimura T., Okada M., Miura T., Hayami M. 1994; Persistent infection with SIVmac chimeric virus having tat , rev , vpu , env and nef of HIV type 1 in macaque monkeys. AIDS Research and Human Retroviruses 10:1021–1029
   [Google Scholar]
10. Kestler H. W., Ringler D. J., Mori K., Panicali D. L., Sehgal P. K., Daniel M. D., Desrosiers R. C. 1991; Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651–662
    [Google Scholar]
11. Kornfeld H., Cruikshank W. W., Pyle S. W., Berman J. S., Center D. M. 1988; Lymphocyte activation by HIV-1 envelope glycoprotein. Nature 355:445–449
    [Google Scholar]
12. Kuwata T., Igarashi T., Ido E., Jin M., Mizuno A., Chen J., Hayami M. 1995; Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication. Journal of General Virology 76:2181–2191
    [Google Scholar]
13. Kuwata T., Shioda T., Igarashi T., Ido E., Ibuki K., Enose Y., Stahl-Hennig C., Hunsmann G., Tomoyuki M., Hayami M. 1996; Chimeric viruses between SIVmac and various HIV-1 isolates have biological properties that are similar to those of the parental HIV-1. AIDS 10:1331–1337
    [Google Scholar]
14. Li J. T., Halloran M., Lord C. I., Watson A., Ranchalis J., Fung M., Letvin N. L., Sodroski J. G. 1995; Persistent infection of macaques with simian-human immunodeficiency viruses. Journal of Virology 69:7061–7071
    [Google Scholar]
15. Norley S., Beer B., Binninger-Schinzel D., Cosma C., Kurth R. 1996; Protection from pathogenic SIVmac challenge following shortterm infection with a nef-deficient attenuated virus. Virology 219:195–205
    [Google Scholar]
16. O’Brien W. A., Grovit-Ferbas K., Namazi A., Ovcak-Derzic S., Wang H. J., Park J., Yeramian C., Mao S. H., Zack J. A. 1995; Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 86:1082–1089
    [Google Scholar]
17. Regier D. A., Desrosiers R. C. 1990; The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Research and Human Retroviruses 6:1221–1231
    [Google Scholar]
18. Rösok B., Voltersvik P., Bjerknes R., Axelsson M., Haaheim L. R., Asjö B. 1996; Dynamics of HIV-1 replication following influenza vaccination of HIV⁺ individuals. Clinical and Experimental Immunology 104:203–207
    [Google Scholar]
19. Rud E. W., Cranage M., Yon J., Quirk J., Ogilve L., Cook N., Webster S., Dennis M., Clarke B. E. 1994; Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. Journal of General Virology 75:529–543
    [Google Scholar]
20. Schäffner J.-W., Dittmer U., Otteken A., Coulibaly C., Bodemer W., Voss G., Hunsmann G. 1994; Comparison of humoral immunity and induction of proliferating T lymphocytes in vaccinia virus-infected rabbits and rhesus macaques. American Journal of Veterinary Research 55:1250–1255
    [Google Scholar]
21. Stahl-Hennig C., Dittmer U., Nißlein T., Petry H., Jurkiewicz E., Fuchs D., Wachter H., Mätz-Rensing K., Kuhn E.-M., Kaup F.-J., Rud E. W., Hunsmann G. 1996; Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus. Journal of General Virology 77:2969–2981
    [Google Scholar]
22. Stanley S. K., Ostrowski M. A., Justement J. S., Gantt K., Hedayati S., Mannix M., Roche K., Schwartzentruber D. J., Fox C. H., Fauci A. S. 1996; Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. New England Journal of Medicine 334:1222–1230
    [Google Scholar]
23. Staprans S. I., Hamilton B. L., Follansbee S. E., Elbeik T., Barbosa P., Grant R. M., Feinberg M. B. 1995; Activation ofvirus replication after vaccination of HIV-1-infected individuals. Journal of Experimental Medicine 182:1727–1737
    [Google Scholar]
24. Villinger F., Folks T. M., Lauro S., Powell J. D., Sundstrom J. B., Mayne A., Ansari A. A. 1996; Immunological and virological studies of natural SIV infection of disease-resistant nonhuman primates. Immunology Letters 51:59–68
    [Google Scholar]
25. Voss G., Dittmer U., Coulibaly C., Makoschey B., Petry H., Leuke W., Hunsmann G. 1994; Differences in the B and T cell immune responses to the envelope glycoprotein 130 of the macaque strain of simian immunodeficiency virus, induced by immunization of rhesus macaques with virus-derived orvaccinia virus-expressedgp130. Journalof General Virology 74:1757–1763
    [Google Scholar]
26. Whatmore A. M., Cook N., Hall G. H., Sharpe S., Rud E. W., Cranage M. P. 1995; Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence. Journal of Virology 69:5117–5123
    [Google Scholar]